These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 482403)

  • 1. Hypothalamic hyperphagia prevented by damage to brain dopamine-containing neurons.
    Rowland N; Marshall JF; Antelman SM; Edwards DJ
    Physiol Behav; 1979 Apr; 22(4):635-40. PubMed ID: 482403
    [No Abstract]   [Full Text] [Related]  

  • 2. 6-Hydroxydopamine-induced blockade of hypothalamic obesity: critical role of brain dopamine-norepinephrine interaction.
    Coscina DV; Nobrega JN
    Prog Neuropsychopharmacol Biol Psychiatry; 1982; 6(4-6):369-72. PubMed ID: 6298885
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reinstatement of eating by dopamine agonists in aphagic dopamine denervated rats.
    Ljungberg T; Ungerstedt U
    Physiol Behav; 1976 Mar; 16(3):277-83. PubMed ID: 1033572
    [No Abstract]   [Full Text] [Related]  

  • 4. Overeating and obesity from damage to a noradrenergic system in the brain.
    Ahlskog JE; Hoebel BG
    Science; 1973 Oct; 182(4108):166-9. PubMed ID: 4517136
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hupothalamic hyperphagia: dissociation from hyperphagia following destruction of noradrenergic neurons.
    Ahlskog JE; Randall PK; Hoebel BG
    Science; 1975 Oct; 190(4212):399-401. PubMed ID: 1179221
    [No Abstract]   [Full Text] [Related]  

  • 6. The role of hypothalamic noradrenergic neurons in food intake regulation.
    Slangen JL
    Prog Brain Res; 1974; 41():395-407. PubMed ID: 4445511
    [No Abstract]   [Full Text] [Related]  

  • 7. Central noradrenergic neurons: differential effects on body weight of electrolytic and 6-hydroxydopamine lesions in rats.
    Lorden J; Oltmans GA; Margules DL
    J Comp Physiol Psychol; 1976 Feb; 90(2):144-55. PubMed ID: 1249269
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypokinesia produced by anterolateral hypothalamic 6-hydroxydopamine lesions and its reversal by some antiparkinson drugs.
    Butterworth RF; Bélanger F; Barbeau A
    Pharmacol Biochem Behav; 1978 Jan; 8(1):41-5. PubMed ID: 625480
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of lesion of cortical dopamine terminals on subcortical dopamine receptors in rats.
    Pycock CJ; Kerwin RW; Carter CJ
    Nature; 1980 Jul; 286(5768):74-6. PubMed ID: 7393327
    [No Abstract]   [Full Text] [Related]  

  • 10. Relationship of dopamine neural systems to the behavioral alterations produced by 6-hydroxydopamine administration into brain.
    Cooper BR; Breese GR
    Adv Biochem Psychopharmacol; 1974; 12(0):353-68. PubMed ID: 4609223
    [No Abstract]   [Full Text] [Related]  

  • 11. The biology of motivation.
    Grossman SP
    Annu Rev Psychol; 1979; 30():209-42. PubMed ID: 375810
    [No Abstract]   [Full Text] [Related]  

  • 12. Overeating after midbrain 6-hydroxydopamine: prevention by central injection of selective catecholamine reuptake blockers.
    Hernandez L; Hoebel BG
    Brain Res; 1982 Aug; 245(2):333-43. PubMed ID: 6812851
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of 6-hydroxydopamine on agonistic behaviour elicited by stimulation of the hypothalamus in the cat.
    Johansson G; Pääkkönen T; Ruusunen S; Sandström M; Huttunen M
    Med Biol; 1974 Dec; 52(6):406-14. PubMed ID: 4374614
    [No Abstract]   [Full Text] [Related]  

  • 14. Enhancement by 6-hydroxydopamine of the effects of DOPA upon the motor activity of rats.
    Schoenfeld RI; Uretsky NJ
    J Pharmacol Exp Ther; 1973 Sep; 186(3):616-24. PubMed ID: 4728340
    [No Abstract]   [Full Text] [Related]  

  • 15. Neuroleptic-like disruption of the conditioned avoidance response requires destruction of both the mesolimbic and nigrostriatal dopamine systems.
    Koob GF; Simon H; Herman JP; Le Moal M
    Brain Res; 1984 Jun; 303(2):319-29. PubMed ID: 6430466
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of dopamine-depleting brain lesions on experimental hyperphagia in rats.
    Rowland N; Stricker EM
    Physiol Behav; 1982 Feb; 28(2):271-7. PubMed ID: 7079339
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dopamine-norepinephrine interactions in the development of hyperphagia and obesity following medial hypothalamic lesions.
    Nobrega JN; Coscina DV
    Pharmacol Biochem Behav; 1986 Aug; 25(2):401-9. PubMed ID: 3094039
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Self-stimulation at the lateral hypothalamus and locus coeruleus after specific unilateral lesions of the dopamine system.
    Koob GF; Fray PJ; Iversen SD
    Brain Res; 1978 May; 146(1):123-40. PubMed ID: 647383
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term effects of insulin in weanling rats with dorsomedial hypothalamic hypophagia: food intake, efficiency of food utilization, body weight and composition.
    Bernardis LL; Luboshitzky R; Bellinger LL
    Physiol Behav; 1981 Sep; 27(3):469-74. PubMed ID: 7038725
    [No Abstract]   [Full Text] [Related]  

  • 20. Properties of ventromedial hypothalamic neurons with axons to midbrain central gray.
    Sakuma Y; Pfaff DW
    Exp Brain Res; 1982; 46(2):292-300. PubMed ID: 6284542
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.